NCI is trading 5.9% down at $10.73 following an isolated after-hours repricing, despite a lack of company-specific news or fresh filings.
- The move appears driven by low-liquidity trading or opportunistic order flow rather than fundamental developments.
- No clear sector-wide shocks or catalysts have emerged in the public domain to explain the downward pressure.